Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Devine

Showing results (11-20 of 178) with videos related to

Pageof 18
Sort By:
Blood|September 17, 2016
How do stem cells mobilize? Bridging the GAPSteven M Devine
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 17, 2014
Reprint of: Re-examining the role of high-dose chemotherapy in the treatment of light chain amyloidosisSteven M Devine
Blood|September 19, 2009
Reduced-intensity conditioning allogeneic stem cell transplantation in HIV patients with hematologic malignancies: yes, we canMehdi Hamadani, Steven M Devine
Blood Advances|February 17, 2026
When remission alone might be good enoughSteven M Devine, Uday Popat
Blood Advances|February 24, 2026
When remission alone might be good enoughSteven M Devine, Uday Popat
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2021
Building a Fit for Purpose Clinical Trials Infrastructure to Accelerate the Assessment of Novel Hematopoietic Cell Transplantation Strategies and Cellular ImmunotherapiesSteven M Devine, Mary M Horowitz
Current Opinion in Hematology|January 29, 2014
Graft-versus-host disease: why have we not made more progress?Samantha M Jaglowski, Steven M Devine
Bone Marrow Transplantation|June 8, 2018
A challenge to discriminating psychosocial eligibility criteria: exploring the ethical justification for excluding patients with psychosocial risk factors from hematopoietic cell transplantationDaniel R Richardson, Steven M Devine, Ryan Nash
Blood|June 5, 2002
Reduced duration of cytopenias following melphalan conditioning and autografting for multiple myelomaSteven M Devine, Balkrishna Jahagirdar, Koen van Besien
Blood Advances|December 24, 2025
A Proposal for Expedited Stem Cell Transplantation for TP53-Mutant Myelodysplastic Neoplasms and Acute Myeloid LeukemiaShyam Ajay Patel, Steven M Devine, Jan Cerny
Pageof 18

Showing results (11-20 of 178) with videos related to

Sort By:
Pageof 18
Blood|September 17, 2016
How do stem cells mobilize? Bridging the GAPSteven M Devine
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 17, 2014
Reprint of: Re-examining the role of high-dose chemotherapy in the treatment of light chain amyloidosisSteven M Devine
Blood|September 19, 2009
Reduced-intensity conditioning allogeneic stem cell transplantation in HIV patients with hematologic malignancies: yes, we canMehdi Hamadani, Steven M Devine
Blood Advances|February 17, 2026
When remission alone might be good enoughSteven M Devine, Uday Popat
Blood Advances|February 24, 2026
When remission alone might be good enoughSteven M Devine, Uday Popat
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2021
Building a Fit for Purpose Clinical Trials Infrastructure to Accelerate the Assessment of Novel Hematopoietic Cell Transplantation Strategies and Cellular ImmunotherapiesSteven M Devine, Mary M Horowitz
Current Opinion in Hematology|January 29, 2014
Graft-versus-host disease: why have we not made more progress?Samantha M Jaglowski, Steven M Devine
Bone Marrow Transplantation|June 8, 2018
A challenge to discriminating psychosocial eligibility criteria: exploring the ethical justification for excluding patients with psychosocial risk factors from hematopoietic cell transplantationDaniel R Richardson, Steven M Devine, Ryan Nash
Blood|June 5, 2002
Reduced duration of cytopenias following melphalan conditioning and autografting for multiple myelomaSteven M Devine, Balkrishna Jahagirdar, Koen van Besien
Blood Advances|December 24, 2025
A Proposal for Expedited Stem Cell Transplantation for TP53-Mutant Myelodysplastic Neoplasms and Acute Myeloid LeukemiaShyam Ajay Patel, Steven M Devine, Jan Cerny
Pageof 18